tlooto

Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

A. Rink, J. Borg, A. Simeonov, Gerald O'Leary, J. Helou, C. Ménard, P. Chung, D. Jaffray, A. Berlin

2017.7.1Brachytherapy

Paper details

Journal
Brachytherapy
Published
2017.7.1
Citations
8
References
19
Fields
Engineering, Medicine

tlooto Summary

Volumetric changes were observed during the time between planning MR and ptMR, resulting in reduction in coverage for both prostate and planning target volume, and treatment plans for both whole- and partial-gland therapies remained clinically acceptable.

Abstract

Abstract is not available.

Citation format

RINK, A., et al. Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer. Brachytherapy, 2017, 17 1(1): 59–67.